NCT06649331
- Conditions
- Advanced Breast Cancer, Breast Cancer, Breast Diseases, +9 more
- Locations
-
- Breast cancer institute of Fudan University Cancer Hospital Shanghai, Shanghai Municipality, China
Clinical trial condition
HER2-negative Breast Cancer
Explore clinical trials studying HER2-negative Breast Cancer. Study availability and eligibility vary by location and protocol.
108 public trials
56 recruiting studies
HER2-negative Breast Cancer trial results
NCT06488378
- Conditions
- BRCA1 Mutation, BRCA2 Mutation, Breast Cancer, +8 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT05868226
- Conditions
- Adenocarcinoma, Adenocarcinoma of Colon, Breast Diseases, +51 more
- Locations
-
- The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
- Moffitt Cancer Center Tampa, Florida, United States
- The University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
- UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital New Lenox, Illinois, United States
NCT06120283
- Conditions
- Advanced Breast Cancer, Advanced Solid Tumor, Breast Diseases, +11 more
- Locations
-
- Sarah Cannon Research Institute (Scri) At Health One Denver, Colorado, United States
- Florida Cancer Specialists and Research Institute Lake Mary, Florida, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
- Washington University School of Medicine St Louis, Missouri, United States
Recruiting
A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer
NCT07227831
- Conditions
- Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- Karmanos Cancer Institute at McLaren Bay Region Bay City, Michigan, United States
- Karmanos Cancer Institute at McLaren Clarkston Clarkston, Michigan, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
- Karmanos Cancer Institute at McLaren Flint Flint, Michigan, United States
NCT06533826
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- University of Alabama Birmingham, Alabama, United States
- University of San Francisco San Francisco, California, United States
- Yale University Cancer Center New Haven, Connecticut, United States
- Georgetown University Medical Center Washington D.C., District of Columbia, United States
NCT06382948
- Conditions
- Advanced Breast Cancer, ER-positive Breast Cancer, ESR1 Gene Mutation, +1 more
- Locations
-
- Medizinische Universität Innsbruck Innsbruck, Austria
- Ordensklinikum Linz Barmherzige Schwestern Linz, Austria
- Ordination Priv.-Doz. Dr. Michael Hubalek Schwaz, Austria
- Medical University of Vienna Vienna, Austria
NCT06993506
- Conditions
- Disease Attributes, HER2-negative Breast Cancer, Metastasis, +6 more
- Locations
-
- Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
- The Second Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
- Peking University First Hospital Beijing, Beijing Municipality, China
- Chinese PLA General Hospital Beijing, Beijing Municipality, China
NCT07602907
- Conditions
- Advanced Breast Cancer, HER2-negative Breast Cancer
- Locations
-
- Zhejiang Cancer Hospital Hangzhou, Zhejiang, China
NCT04585750
- Conditions
- Adnexal Diseases, Advanced Malignant Neoplasm, Advanced Solid Tumor, +81 more
- Locations
-
- University of California Irvine Chao Family Comprehensive Cancer Center Irvine, California, United States
- University of San Diego Moores Cancer Center La Jolla, California, United States
- UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States